Beyond the brain: A link between hearing loss and autism spectrum disorder

by Josef Blaszkiewicz,Medical University of South CarolinaExpression of the MEF2C protein (green) in the nuclei of neuronal cells (stained with a neuronal marker protein in red) in the inner ear

Updated on: February 05,2024

Beyond the brain: A link between hearing loss and autism spectrum disorder

by Josef Blaszkiewicz,Medical University of South CarolinaExpression of the MEF2C protein (green) in the nuclei of neuronal cells (stained with a neuronal marker protein in red) in the inner ear

Updated on:February 05,2024

Researchers discover role of microglia during early progression of Alzheimer's disease

by Boston University Medical CenterDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.For the first time, researchers have determined how toxic tau fib

Updated on: February 26,2024

Researchers discover role of microglia during early progression of Alzheimer's disease

by Boston University Medical CenterDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.For the first time, researchers have determined how toxic tau fib

Updated on:February 26,2024

Blood-based biomarkers for Alzheimer's disease could greatly simplify diagnosis and reduce costs

by Hôpitaux Universitaires de GenèveProportion of traditional exams that could be saved by using plasma biomarkers with 95%-sensitivity or 95%-specificity cut-offs. Values indicate the proportion of s

Updated on: June 18,2024

Blood-based biomarkers for Alzheimer's disease could greatly simplify diagnosis and reduce costs

by Hôpitaux Universitaires de GenèveProportion of traditional exams that could be saved by using plasma biomarkers with 95%-sensitivity or 95%-specificity cut-offs. Values indicate the proportion of s

Updated on:June 18,2024

A new approach to treating amyotrophic lateral sclerosis and frontotemporal dementia

by Academia SinicaSchematic representation of mechanisms involved in poly-GR/-PR-induced neuronal degradation and the potential therapeutic action of the sulfated disaccharide SOS. Credit: Academia Si

Updated on: March 28,2024

A new approach to treating amyotrophic lateral sclerosis and frontotemporal dementia

by Academia SinicaSchematic representation of mechanisms involved in poly-GR/-PR-induced neuronal degradation and the potential therapeutic action of the sulfated disaccharide SOS. Credit: Academia Si

Updated on:March 28,2024

Genome-wide transcriptome profiling and development of age prediction models in the human brain

by Impact Journals LLCDifferential gene expression analysis overall and by sex. Credit:Aging(2024). DOI: 10.18632/aging.205609A new research paper was published inAgingentitled

Updated on: March 19,2024

Genome-wide transcriptome profiling and development of age prediction models in the human brain

by Impact Journals LLCDifferential gene expression analysis overall and by sex. Credit:Aging(2024). DOI: 10.18632/aging.205609A new research paper was published inAgingentitled

Updated on:March 19,2024

Research links age-related inflammation, microglia and Alzheimer's disease

by Nicholas Weiler,Stanford UniversityMyeloid TREM1 expression positively associates with increasing AD pathology. Credit:Nature Neuroscience(2024). DOI: 10.1038/s41593-024-01610-wSt

Updated on: March 30,2024

Research links age-related inflammation, microglia and Alzheimer's disease

by Nicholas Weiler,Stanford UniversityMyeloid TREM1 expression positively associates with increasing AD pathology. Credit:Nature Neuroscience(2024). DOI: 10.1038/s41593-024-01610-wSt

Updated on:March 30,2024

New Alzheimer risk gene discovered

by Oxford University PressCredit: CC0 Public DomainA new paper in theJournal of Neuropathology & Experimental Neurologyfinds a gene that may help explain a large part of the genet

Updated on: June 01,2024

New Alzheimer risk gene discovered

by Oxford University PressCredit: CC0 Public DomainA new paper in theJournal of Neuropathology & Experimental Neurologyfinds a gene that may help explain a large part of the genet

Updated on:June 01,2024

More years of education reduces risk of dementia

by CHeBA's The Dementia Momentum InitiativeCredit: DreamstimeAn international research study led by the Centre for Healthy Brain Ageing (CHeBA) at UNSW Sydney has provided further support to the f

Updated on: June 05,2024

More years of education reduces risk of dementia

by CHeBA's The Dementia Momentum InitiativeCredit: DreamstimeAn international research study led by the Centre for Healthy Brain Ageing (CHeBA) at UNSW Sydney has provided further support to the f

Updated on:June 05,2024

Pathway deep in the brain makes it resilient after injury

by Sarah Williams,Gladstone InstitutesA new study led by Gladstone researchers suggests that targeting a protein in the thalamus could prevent the long-term damage that follows traumatic brain i

Updated on: February 21,2024

Pathway deep in the brain makes it resilient after injury

by Sarah Williams,Gladstone InstitutesA new study led by Gladstone researchers suggests that targeting a protein in the thalamus could prevent the long-term damage that follows traumatic brain i

Updated on:February 21,2024

Hidden financial dimensions affect people with cognitive decline and their care partners, report says

by The Gerontological Society of AmericaCredit: CC0 Public DomainIn planning for older adulthood, many people both fear and consistently underestimate the risk of Alzheimer's disease and related d

Updated on: April 29,2024

Hidden financial dimensions affect people with cognitive decline and their care partners, report says

by The Gerontological Society of AmericaCredit: CC0 Public DomainIn planning for older adulthood, many people both fear and consistently underestimate the risk of Alzheimer's disease and related d

Updated on:April 29,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024

New link between increased astrocytes in the brain and blood in early Alzheimer's disease

by Karolinska InstitutetBrain regions with increased astrocytes that can appear in the blood. Credit: Konstantinos ChiotisA new study shows that the activation of the brain's immune defense c

Updated on: March 02,2024

New link between increased astrocytes in the brain and blood in early Alzheimer's disease

by Karolinska InstitutetBrain regions with increased astrocytes that can appear in the blood. Credit: Konstantinos ChiotisA new study shows that the activation of the brain's immune defense c

Updated on:March 02,2024